Clinical Trial Update: First-In-Human Study of ChAdOx1-HBV & MVA-HBV Vaccines (VTP-300) for Chronic HBV [Phase 1, Phase 2]

View source ↗

Summary

A first-in-human study of ChAdOx1-HBV and MVA-HBV vaccines (VTP-300) for chronic hepatitis B completed Phase 1/2, with results posted in August 2024.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• ChAdOx1-HBV vaccine (ChAdOx1-HBV)
• MVA-HBV vaccine (MVA-HBV)

Snippet

Sponsor: Barinthus Biotherapeutics | Conditions: Hepatitis B | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2024-08-13